Levels of acute phase proteins remain stable after ischemic stroke

BMC Neurology

Volumn 6, Issue , 2006, Pages

  Elkind, Mitchell S V ^a,b   Coates, Kristen ^b   Tai, Wanling ^c   Paik, Myunghee C ^c   Boden Albala, Bernadette ^c   Sacco, Ralph L ^a,b,c  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b NONE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; INSULIN; ORAL ANTIDIABETIC AGENT; SERUM AMYLOID A;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HISPANIC; HUMAN; HYPERTENSION; INFLAMMATION; MALE; PROTEIN BLOOD LEVEL; RATING SCALE; SCORING SYSTEM; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS;

ACUTE-PHASE REACTION; ADULT; AGED; C-REACTIVE PROTEIN; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SERUM AMYLOID A PROTEIN; STATISTICS, NONPARAMETRIC; STROKE; TIME FACTORS;

EID: 33750414097     PISSN: 14712377     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-6-37     Document Type: Article

References (27)

1. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-26.
2. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F: Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499-511.
3. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E: C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005, 352:20-8.
4. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E: Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000, 101:2149-53.
5. Biasucci LN, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, Dinarello CA, Maseri A: Increasing levels of interleukin (IL)-IRa and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 1999, 99:2079-84.
6. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, Summaria F, Ginnetti F, Fadda G, Maseri A: Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999, 99:855-60.
7. Vila N, Castillo J, Davalos A, Chamorro A: Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000, 31:2325-9.
8. Beamer NB, Coull BM. Clark WM, Hazel JS, Silberger JR: Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 1995, 37:800-5.
9. Arenillas JF, Alvarez-Sabin J, Molina CA, Chacon P, Montaner J, Rovira A, Ibarra B, Quintana M: C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 2003, 34:2463-70.
10. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR: C-reactive protein and outcome after ischemic stroke. Stroke 1999, 30:981-5.
11. Di Napoli M, Papa F, Bocola V: Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001, 32:133-8.
12. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D: Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 2002 33:2459-64.
13. Woodward M, Lowe GDO, Campbell DJ, Colman S, Rumley A, Chalmers J, Neal BC, Patel A, Jenkins AJ, Kemp BE, MacMahon SW: Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke 2005, 36:2143-2147.
14. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C, Emsley HC, Forconi S, Hopkins SJ, Masotti L, Muir KW, Paciucci A, Papa F, Roncacci S, Sander D, Sander K, Smith CJ, Stefanini A. Weber D: Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 2005, 36:1316-29.
15. Sacco RL, Elkind MS, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, Shea S, Paik MC: The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999, 281:53-60.
16. Elkind MSV, Cheng J, Rundek T, Boden-Albala B, Sacco RL: Leukocyte count predicts outcome after ischemic stroke: The Northern Manhattan Stroke Study. J Stroke Cerebrovasc Dis 2004, 13:220-227.
17. Kargman DE, Tuck C, Berglund L, Lin IF, Mukherjee RS, Thompson EV, Jones J, Boden-Albala B, Paik MC, Sacco RL: Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study. Atherosclerosis 1998, 139:391-9.
18. Gentry EM, Kalsbeek WD, Hegelin G, Jones JT, Gaines KL, Forman MR, Marks JS, Trowbridge FL: The Behavioral Risk Factor Surveys: II. Design, methods, and estimates from combined state data. Am J Prev Med 1985, 1:9-14.
19. Gan R, Sacco RL, Kargman DE, Roberts JK, Boden-Albala B, Gu Q: Testing the validity of the lacunar hypothesis: The Northern Manhattan Stroke Study experience. Neurology 1997, 48:1204-11.
20. Beamer NB, Coull BM, Clark WM, Briley DP, Wynn M, Sexton G: Persistent inflammatory response in stroke survivors. Neurology 1998, 50:1722-1728.
21. Di Napoli M, Papa F, Bocola V: C-Reactive Protein in ischemic stroke. An independent Prognostic factor. Stroke 2001 32:917-924.
22. Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N, Nakamura Y, Itoh Y, Kajii E: Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population. Am J Epidemiol 2001, 153:1183-90.
23. Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM: Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 2002, 89:1117-9.
24. Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, Kuller LH: Lifetime smoking exposure affects the association between of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 1997, 17:2167-76.
25. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, Wians FH, Grundy SM, de Lemos JA: Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005, 46:464-469.
26. Best LG, Zhang Y, Lee ET, Yeh JL, Cowan L, Palmieri V, Roman M, Devereux RB, Fabsitz RR, Tracy RP, Robbins D, Davidson M, Ahmed A, Howard BV: C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study. Circulation 2005, 112:1289-1295.
27. Curb JD, Abbott RD, Rodriguez BL, Sakkinen P, Popper JS, Yano K, Tracy RP: C-reactiye protein and the future risk of thromboembolic stroke in healthy men. Circulation 2003, 107:2016-20.